Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System

(2021) Nabeel Khan et al.   GUT

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

(2021) Nicholas A Kennedy et al.   GUT

Pathway paradigms revealed from the genetics of inflammatory bowel disease

(2020) Daniel B. Graham et al.   NATURE

2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases

(2020) Carlos Taxonera et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts

(2020) Mariangela Allocca et al.   Clinical Gastroenterology and Hepatology

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California

(2020) John Gubatan et al.   GASTROENTEROLOGY

Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study

(2020) Nabeel Khan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

SARS-CoV-2 vaccines in development

(2020) Florian Krammer   NATURE

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study

(2018) Nabeel Khan et al.   Clinical Gastroenterology and Hepatology

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

(2018) Julien Kirchgesner et al.   GASTROENTEROLOGY

Immortal time bias in observational studies of time-to-event outcomes

(2016) Mark Jones et al.   JOURNAL OF CRITICAL CARE

Inflammatory Bowel Disease and the Elderly: A Review

(2015) S. Taleban et al.   Journal of Crohns & Colitis

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies

(2015) Peter C. Austin et al.   STATISTICS IN MEDICINE

Issues regarding ‘immortal time’ in the analysis of the treatment effects in observational studies

(2011) Jiannong Liu et al.   KIDNEY INTERNATIONAL

Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease

(2009) Gil Y Melmed et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

(2009) Peter C. Austin   STATISTICS IN MEDICINE

Infections and IBD

(2008) Peter M Irving et al.   Nature clinical practice. Gastroenterology & hepatology